Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating expenses
Research and development	$ 217,582	$ 243,453
Selling, general and administrative	1,044,600	593,549
Total operating expenses	1,262,182	837,002
Income (loss) from operations	(1,262,182)	(837,002)
Other Income (expenses):
Gain on sale of assets and technology	600,000
Gain on forgiveness of accounts payable	68,032	1,659,917
Interest expense	(57,400)	(43,787)
Total other Income (expenses)	610,632	1,616,130
Net Income (loss)	(651,550)	779,128
Net Income (loss) attributable to the non-controlling interest	(133,653)	(87,547)
Net Income (Loss) attributable to the controlling interest	$ (517,897)	$ 866,675
Net Income (Loss) per share-basic and diluted	$ (0.02)	$ 0.05
Weighted average number of common shares outstanding - basic and diluted	24,116,244	14,485,604